2021 Webinar: Use of Serum and Imaging Biomarkers of NAFLD/NASH in Clinical Practice
Image For Activity Cover
Credit Offered
No Credit Offered
  • Description
  • Summary
  • Recommended
This on-demand webinar will update the audience on the most recent data in non-invasive testing (NITs) biomarkers in NAFLD/NASH (including use for staging, monitoring disease progression and response to therapy). We will focus on three key areas: serum-based biomarkers, imaging-based biomarkers and how to use combination or sequential NITs. At the conclusion of the webinar, learners will have an update on knowledge of various biomarkers in NAFLD and a path to apply best practices in their setting.
Webinar hosted by the Nonalcoholic Fatty Liver Disease Special Interest Group on February 17, 2021.
Powered By